F. Hoffmann-La Roche Ltd

Companies & groups

Roche has grown into one of the world’s largest biotechnology companies, as well as a leading provider of in-vitro diagnostics. Dedicated to scientific excellence, our company develops innovative medicines and diagnostics to save and improve the lives of patients across the globe. More than 44 medicines and diagnostics developed by Roche are included in the WHO Model Lists of Essential Medicines and Tests. For 15 consecutive years, our company was ranked one of the most sustainable companies by the Dow Jones Sustainability Indices. Roche currently employs over 112,000 people in more than 100 countries. In 2025, Roche invested approximately CHF 12.2 billion in R&D and posted sales of CHF 61.5 billion. Genentech, Flatiron Health, Foundation Medicine, and Spark Therapeutics, all based in the US, are wholly owned members of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com.

18940431725-51

Basel

SW

business_company

Corporation